Precigen, Inc. (PGEN)
3.375
-0.24
(-6.77%)
USD |
NASDAQ |
Mar 03, 16:00
3.38
0.00 (0.00%)
After-Hours: 20:00
Precigen Free Cash Flow : -75.62M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Marker Therapeutics, Inc. | -14.82M |
| Amneal Pharmaceuticals, Inc. | 225.64M |
| Corcept Therapeutics, Inc. | 141.78M |
| ADMA Biologics, Inc. | 27.50M |
| Viridian Therapeutics, Inc. | -277.36M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -29.07M |
| Cash from Investing (Quarterly) | -63.39M |
| Cash from Financing (Quarterly) | 93.01M |
| Free Cash Flow Per Share (Quarterly) | -0.0959 |
| Free Cash Flow to Equity (Quarterly) | -122.50M |
| Free Cash Flow to Firm (Quarterly) | -28.56M |
| Free Cash Flow Yield | -7.53% |